Princeton, NJ June 13, 2023: Sociavi Company today announced that David S. Duplay, a veteran healthcare and technology executive, will join its Management Team as Chief Executive Officer effective June 14. Mr. Duplay, a well-respected executive with deep experience in customer-facing and digital health companies, will lead Sociavi in its next phase of growth. He will expand Sociavi’s global B2B strategy and scale their Digital Health Companion™, patient and caregiver support, and customer solutions.

“We are honored to welcome Dave Duplay to Sociavi as our new Chief Executive Officer,” said Paula Muller, Founder and Chief Product Officer of Sociavi. “Dave’s extensive background, including roles at high-profile, global healthcare firms along with innovative health-technology companies, brings a welcome and strategic perspective as we continue to focus on expanding our customer solutions, brand, and reach of our Digital Health Companion™.”

“I am incredibly excited and honored to join Sociavi and work alongside the outstanding and extraordinarily talented executive team and associates,” said Dave Duplay. “Sociavi provides its industry customers, patients, and caregivers with a very valuable service through its Digital Health Companion™. The Sociavi Digital Health Companion™ delivers branded and unbranded health education, provides patient and caregiver research, real-time health & wellness insights, and Virtual Social Therapy®, leading to reduced medical costs, medication compliance, and improved health outcomes.

“Expanding the company’s solution set through our innovative and patented digital health platform, mobile apps, and strategic partnerships will be a top priority as we continue to evolve and scale the business globally,” stated Duplay.

About Sociavi
Sociavi is a leading global digital health firm that provides its customers with patient education, Virtual Social Therapy®, and cognitive exercises and activities through its brain fitness programs. Its mission is to provide value-added services that improve health outcomes through its patented, easy-to-use touchscreen device and companion mobile app.